0000950170-24-077905.txt : 20240626
0000950170-24-077905.hdr.sgml : 20240626
20240626163258
ACCESSION NUMBER: 0000950170-24-077905
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240625
FILED AS OF DATE: 20240626
DATE AS OF CHANGE: 20240626
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Betz Stephen F.
CENTRAL INDEX KEY: 0001886575
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38583
FILM NUMBER: 241073848
MAIL ADDRESS:
STREET 1: 10222 BARNES CANYON ROAD
STREET 2: BUILDING 2
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Crinetics Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001658247
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 263744114
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 10222 BARNES CANYON ROAD, BLDG. #2
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: 858-450-6464
MAIL ADDRESS:
STREET 1: 10222 BARNES CANYON ROAD, BLDG. #2
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
4
1
ownership.xml
4
X0508
4
2024-06-25
false
0001658247
Crinetics Pharmaceuticals, Inc.
CRNX
0001886575
Betz Stephen F.
C/O CRINETICS PHARMACEUTICALS, INC.
6055 LUSK BOULEVARD
SAN DIEGO
CA
92121
false
true
false
false
Chief Scientific Officer
true
Common Stock
2024-06-25
4
S
false
3000
45.37
D
80643
D
The sale reported in this Form 4 was effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
The common stock was sold by the reporting person in open market transactions on the transaction date, with a volume weighted average sales price of $45.37 per share. The range of sales prices on the transaction date was $45.16 to $46.06 per share. Detailed information on the exact number of shares can be obtained from the issuer upon request.
Marc Wilson, as attorney-in-fact
2024-06-26